IT220347Z2 -
PERFECTED AUGER FOR EQUIPMENT FOR SHREDDING AND MIXING OF FIBROUS PRODUCTS INTENDED FOR THE PREPARATION OF FOOD FOR ZOOTECHNICAL USE
- Google Patents
PERFECTED AUGER FOR EQUIPMENT FOR SHREDDING AND MIXING OF FIBROUS PRODUCTS INTENDED FOR THE PREPARATION OF FOOD FOR ZOOTECHNICAL USE
Info
Publication number
IT220347Z2
IT220347Z2IT2201190UIT2201190UIT220347Z2IT 220347 Z2IT220347 Z2IT 220347Z2IT 2201190 UIT2201190 UIT 2201190UIT 2201190 UIT2201190 UIT 2201190UIT 220347 Z2IT220347 Z2IT 220347Z2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sgariboldi Di Sgariboldi GiusefiledCriticalSgariboldi Di Sgariboldi Giuse
Priority to IT2201190UpriorityCriticalpatent/IT220347Z2/en
Publication of IT9022011V0publicationCriticalpatent/IT9022011V0/en
Publication of IT9022011U1publicationCriticalpatent/IT9022011U1/en
Application grantedgrantedCritical
Publication of IT220347Z2publicationCriticalpatent/IT220347Z2/en
IT2201190U1990-10-251990-10-25
PERFECTED AUGER FOR EQUIPMENT FOR SHREDDING AND MIXING OF FIBROUS PRODUCTS INTENDED FOR THE PREPARATION OF FOOD FOR ZOOTECHNICAL USE
IT220347Z2
(en)
Fungicidal compositions based on 3-phenylpyrazole derivatives for the treatment of plant propagation material new 3-phenylpyrazole derivatives and their fungicidal applications
EQUIPMENT FOR CRUSHING AND MIXING FIBROUS PRODUCTS INTENDED FOR THE PREPARATION OF FOOD IN LIVESTOCK, EQUIPPED WITH A MIXER DEVICE TO AVOID STAGNATION OF THE PRODUCT IN PROCESSING
SEPARATION OF SIMATEROL ENANSIOMER, (-) - SIMATEROL AND USE OF SUCH MATERIALS AS PHARMACEUTICAL COMPOSITIONS OR AS A BINDER OF POWER USE IN LIVESTOCK FOOD
CONTRAST DEVICE FOR THE ROTATION OF THE PRODUCT IN SHREDDING EQUIPMENT AND MIXING OF FIBROUS PRODUCTS INTENDED FOR THE PREPARATION OF FOOD IN THE ZOOTECHNICS
New pharmaceutical compositions and new pharmaceutical products allowing the regentation of leukocytes and their use in the treatment of acquired immunodeficient syndrom